X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14114) 14114
Book Chapter (109) 109
Magazine Article (64) 64
Newsletter (25) 25
Book / eBook (18) 18
Newspaper Article (16) 16
Publication (8) 8
Conference Proceeding (5) 5
Web Resource (4) 4
Dissertation (3) 3
Book Review (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11828) 11828
anticoagulants - therapeutic use (5819) 5819
female (5575) 5575
heparin, low-molecular-weight - therapeutic use (4978) 4978
male (4734) 4734
heparin (4169) 4169
molecular-weight heparin (3737) 3737
middle aged (3313) 3313
aged (3001) 3001
hematology (2957) 2957
heparin - therapeutic use (2911) 2911
anticoagulants (2864) 2864
adult (2767) 2767
thrombosis (2434) 2434
risk factors (2382) 2382
peripheral vascular disease (2360) 2360
venous thromboembolism (2337) 2337
thromboembolism (2221) 2221
anticoagulants - adverse effects (2087) 2087
unfractionated heparin (2041) 2041
treatment outcome (2026) 2026
prevention (1990) 1990
deep-vein thrombosis (1808) 1808
anticoagulants - administration & dosage (1737) 1737
fibrinolytic agents - therapeutic use (1713) 1713
surgery (1585) 1585
enoxaparin (1473) 1473
heparin - adverse effects (1469) 1469
animals (1440) 1440
pregnancy (1414) 1414
medicine, general & internal (1298) 1298
pharmacology & pharmacy (1291) 1291
cardiac & cardiovascular systems (1194) 1194
thromboembolism - prevention & control (1167) 1167
anticoagulation (1163) 1163
venous thrombosis - prevention & control (1159) 1159
warfarin (1150) 1150
aged, 80 and over (1145) 1145
heparin, low-molecular-weight - administration & dosage (1117) 1117
heparin, low-molecular-weight - adverse effects (1115) 1115
venous thrombosis - drug therapy (1113) 1113
retrospective studies (1085) 1085
prophylaxis (1071) 1071
risk (1057) 1057
medicine & public health (1054) 1054
care and treatment (1041) 1041
therapy (1030) 1030
venous thrombosis (1030) 1030
venous thromboembolism - prevention & control (1028) 1028
drug therapy (1016) 1016
hemorrhage - chemically induced (1001) 1001
pulmonary embolism (991) 991
prospective studies (970) 970
pulmonary-embolism (959) 959
postoperative complications - prevention & control (941) 941
heparin - administration & dosage (921) 921
low molecular weight heparin (892) 892
cancer (869) 869
time factors (855) 855
health aspects (841) 841
enoxaparin - therapeutic use (837) 837
management (830) 830
thrombocytopenia - chemically induced (827) 827
low-molecular-weight heparin (821) 821
warfarin - therapeutic use (794) 794
analysis (789) 789
glycosaminoglycans (770) 770
aspirin (738) 738
randomized controlled trials as topic (728) 728
thrombosis - prevention & control (726) 726
thromboprophylaxis (716) 716
risk assessment (699) 699
diagnosis (698) 698
research (695) 695
molecular weight (689) 689
anticoagulants - pharmacology (687) 687
mortality (685) 685
platelet aggregation inhibitors - therapeutic use (680) 680
aspirin - therapeutic use (658) 658
pulmonary embolism - prevention & control (658) 658
complications (649) 649
heparin-induced thrombocytopenia (638) 638
dose-response relationship, drug (637) 637
venous thrombosis - etiology (632) 632
risk-factors (624) 624
abridged index medicus (617) 617
adolescent (617) 617
clinical trials as topic (601) 601
recurrence (593) 593
patients (590) 590
oncology (588) 588
pulmonary embolism - drug therapy (581) 581
incidence (577) 577
thrombosis - drug therapy (564) 564
cardiology (563) 563
venous thromboembolism - drug therapy (560) 560
practice guidelines as topic (552) 552
neoplasms - complications (548) 548
heparin - pharmacology (545) 545
thromboembolism - drug therapy (544) 544
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (11) 11
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Scarborough Hospital - Online (1) 1
Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13456) 13456
French (366) 366
German (290) 290
Spanish (144) 144
Chinese (71) 71
Russian (50) 50
Polish (39) 39
Italian (37) 37
Japanese (36) 36
Portuguese (26) 26
Dutch (24) 24
Danish (20) 20
Hungarian (18) 18
Czech (17) 17
Bulgarian (15) 15
Turkish (11) 11
Finnish (8) 8
Swedish (7) 7
Hebrew (6) 6
Croatian (5) 5
Norwegian (5) 5
Serbian (5) 5
Slovak (4) 4
Ukrainian (3) 3
Korean (2) 2
Lithuanian (2) 2
Romanian (2) 2
Bosnian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of internal medicine, ISSN 0003-4819, 07/2008, Volume 149, Issue 2, pp. 73 - 82
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2008, Volume 99, Issue 5, pp. 807 - 818
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10060, pp. 2570 - 2572
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 01/2010, Volume 8, Issue 1, pp. 107 - 113
Introduction: We tested the efficacy and safety of fixed doses of low‐molecular‐weight heparin (LMWH) in patients requiring interruption of vitamin... 
chronic oral anticoagulation | fixed doses | perioperative bridging | low‐molecular‐weight heparin | Chronic oral anticoagulation | Fixed doses | Perioperative bridging | Low-molecular-weight heparin | SURGERY | REGIMEN REGISTRY | HEART-VALVE REPLACEMENT | PERIOPERATIVE MANAGEMENT | BRIDGING THERAPY | ATRIAL-FIBRILLATION | VITAMIN-K-ANTAGONISTS | WARFARIN | PERIPHERAL VASCULAR DISEASE | low-molecular-weight heparin | INTERNATIONAL NORMALIZED RATIO | HEMATOLOGY | UNFRACTIONATED HEPARIN | Prospective Studies | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Nadroparin - administration & dosage | Warfarin - administration & dosage | Feasibility Studies | Postoperative Hemorrhage - blood | Enoxaparin - administration & dosage | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Time Factors | Aged, 80 and over | Adult | Female | Surgical Procedures, Operative - adverse effects | Drug Administration Schedule | Risk Assessment | Administration, Oral | Risk Factors | Thromboembolism - etiology | Anticoagulants - adverse effects | Postoperative Hemorrhage - etiology | Thromboembolism - blood | Aged | Heparin, Low-Molecular-Weight - administration & dosage | Care and treatment | Safety regulations | Heparin | Thromboembolism | Health aspects
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 2017, Volume 22, Issue 5, p. 728
Journal Article